Abiraterone acetate with prednisone reduces risk for prostate cancer death – Healio


Telegraph.co.uk

Abiraterone acetate with prednisone reduces risk for prostate cancer death
Healio
CHICAGO — The addition of abiraterone acetate with prednisone to standard hormonal therapy led to a 38% lower risk for death in men with high-risk, metastatic prostate cancer, according to results of the phase 3 LATITUDE trial presented at the ASCO …
Prostate cancer treatment ‘could help more patients’BBC News
Hope for 20000 prostate cancer patients after ‘world’s biggest treatment’ trialThe Independent
Adding abiraterone to standard treatment improves prostate cancer survival by 40 percent Cancer Research UKEurekAlert (press release)
Bloomberg –UroToday –gulfnews.com –Telegraph.co.uk
all 29 news articles »

Source link